Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.

Saved in:
Bibliographic Details
Title: Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.
Authors: Lee WH; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; General Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC.; Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan, ROC., Hou HA; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC. hsinanhou@ntu.edu.tw.; General Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC. hsinanhou@ntu.edu.tw.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC. hsinanhou@ntu.edu.tw.; School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC. hsinanhou@ntu.edu.tw., Lin CC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC., Tsai XC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC., Tien FM; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC., Lo MY; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Department of Internal Medicine, National Taiwan University Hospital, Yunlin Branch, Yunlin, Taiwan, ROC., Chang YS; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC., Peng YL; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC., Tseng MH; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan, ROC., Kuo YY; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan, ROC., Yu SC; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan, ROC., Liu MC; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan, ROC., Yao CY; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC., Hsu CL; Department of Medical Research, National Taiwan University, Taipei, Taiwan, ROC., Yuan CT; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Department of Pathology, National Taiwan University Hospital Cancer Center Branch, Taipei, Taiwan, ROC., Yao M; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Division of Cellular Therapy, Department of Integrated Diagnostics & Therapeutics, National Taiwan University Hospital, Taipei, Taiwan, ROC., Tien HF; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei, Taiwan, ROC., Ko BS; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC. bskomd@ntu.edu.tw.; School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC. bskomd@ntu.edu.tw.; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan, ROC. bskomd@ntu.edu.tw.; Department of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan, ROC. bskomd@ntu.edu.tw., Chou WC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC.
Source: Blood cancer journal [Blood Cancer J] 2026 Mar 12; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 12.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2044-5385
DOI:10.1038/s41408-026-01456-4